CERS

Cerus Corporation (CERS)

About Cerus Corporation (CERS)

Cerus Corp. engages in the research, development, and manufacturing of biomedical and surgical products. The firm produces blood system for platelets and plasma. It operates through Blood Safety segment. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.

Details

Daily high

$1.55

Daily low

$1.51

Price at open

$1.52

52 Week High

$2.58

52 Week Low

$1.38

Market cap

289.7M

Dividend yield

0.00%

Volume

422,479

Avg. volume

1.2M

P/E ratio

-14.50

Cerus Corporation News